NYSE - Nasdaq Real Time Price USD

Cardinal Health, Inc. (CAH)

Compare
116.35 +0.22 (+0.19%)
As of 9:32 AM EST. Market Open.
Loading Chart for CAH
DELL
  • Previous Close 116.13
  • Open 112.87
  • Bid --
  • Ask --
  • Day's Range 115.62 - 116.94
  • 52 Week Range 93.17 - 119.13
  • Volume 54,937
  • Avg. Volume 1,891,206
  • Market Cap (intraday) 28.157B
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) 22.37
  • EPS (TTM) 5.20
  • Earnings Date Jan 30, 2025 - Feb 3, 2025
  • Forward Dividend & Yield 2.02 (1.74%)
  • Ex-Dividend Date Oct 1, 2024
  • 1y Target Est 123.48

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

www.cardinalhealth.com

47,922

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CAH

View More

Performance Overview: CAH

Trailing total returns as of 11/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CAH
16.54%
S&P 500
20.03%

1-Year Return

CAH
17.81%
S&P 500
31.37%

3-Year Return

CAH
148.43%
S&P 500
22.85%

5-Year Return

CAH
167.41%
S&P 500
86.68%

Compare To: CAH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CAH

View More

Valuation Measures

Annual
As of 11/1/2024
  • Market Cap

    28.10B

  • Enterprise Value

    30.40B

  • Trailing P/E

    22.33

  • Forward P/E

    15.24

  • PEG Ratio (5yr expected)

    1.00

  • Price/Sales (ttm)

    0.13

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.14

  • Enterprise Value/EBITDA

    11.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.57%

  • Return on Assets (ttm)

    3.18%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    224.45B

  • Net Income Avi to Common (ttm)

    1.28B

  • Diluted EPS (ttm)

    5.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.87B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.91B

Research Analysis: CAH

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 52.28B
Earnings 416M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

101.00 Low
123.48 Average
116.35 Current
145.00 High
 

Company Insights: CAH

Research Reports: CAH

View More
  • Cardinal Health Earnings: Optum Loss Doesn't Stop a Strong Result

    Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

    Rating
    Price Target
     
  • Raising target to $125

    Cardinal is one of the nation's largest pharmaceutical and medical distribution companies. Its Pharmaceutical segment distributes a wide range of branded and generic drugs, specialty drugs, and over-the-counter products. The Medical segment distributes medical, surgical, and laboratory products to hospitals and other healthcare providers. The company has about 44,000 employees. The shares are a component of the S&P 500.

    Rating
    Price Target
     
  • September 10 was very reminiscent of the mega-cap market from parts of 2023

    September 10 was very reminiscent of the mega-cap market from parts of 2023 and 2024, when just a handful of monster stocks dragged the major indices higher, while most other stocks waded in choppy water. While the biggest sector winner was Real Estate (XLRE), with a 1.8% gain, Information Technology (IT) was second, rising 1.5%, and Consumer Discretionary was third, adding 1.2%. Within IT, software rose 1.9% on the back of Oracle's 11% surge following better-than-expected quarterly results. Semiconductors also got a little mojo back, rising a bit more than 3% as Broadcom popped 5.3% and Advanced Micro added 3.4%. Autos led in discretionary as Tesla ripped 4.6% while the next 10 autos by market cap all fell. On the flipside, Financial gave up 1%, led by a 5.2% drubbing in the largest bank, JP Morgan. Energy was the weakest sector, as crude oil fell another 3.5% to $66.30/barrel and the lowest close for WTI since late 2021. Exxon led Energy to the downside, falling 3.6%. While the S&P 500 gained 0.5%, the Nasdaq rose 0.8%, Nasdaq 100 was up 0.9%, small- and mid-caps did little, and NYSE breadth was flat. Bonds continue to rally as the 10-year yield fell to 3.65%, the lowest level since June 2023; the five-year dropped to 3.43%, its lowest since May 2023; while the two-year is down to 3.59%, the lowest since March 2023. While it's happening slowly, the yield is normalizing - in other words, it is 'un-inverting' for the first time in over two years. The two-, five-, and 10-year yield charts all look like they are tracing out multi-year topping formations, but we don't want rates to fall too far.

     
  • Daily – Vickers Top Buyers & Sellers for 08/20/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch